Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros







Base de dados
Intervalo de ano de publicação
1.
Int. braz. j. urol ; 45(4): 775-781, July-Aug. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1019893

RESUMO

ABSTRACT Purpose To identify how the most frequently used parameters in daily clinical practice diagnosing bladder outlet obstruction (BOO) due to benign prostate hyperplasia (BPH) correlate to each other. Materials and methods The study included 452 patients with lower urinary tract symptoms (LUTS) of the UNICAMP urology outpatient clinic of LUTS. Inclusion criteria: patients with BOO due to BPH who agreed to participate in the study. Exclusion criteria: patients with urinary tract infection, neurological diseases that compromised the lower urinary tract, prior prostatic surgery, radiotherapy or urethral stenosis. Patient assessment: history, international prostate symptoms score (IPSS), nocturnal quality of life score (NQoL) questionnaires, physical and digital rectal examination (DRE), PSA, transabdominal ultrasound with intravesical prostate protrusion (IPP), post-mictional residue and free uroflowmetry. Results There was no strong Spearman correlation among the studied variables. The only moderate correlations occurred between IPSS and NQoL (p <0001; c=0.56) and between IPP and prostate volume (p <0001; c=0.57). Weak correlations between IPP and post-mictional residue (p <0001; c=0.31) and free uroflowmetry (p <0001; c=-0.26); and between IPSS and free uroflowmetry (p <0001, c=-0.21) were observed. Conclusion In this study, we found moderate, weak, very weak and absent correlation among the various parameters used in the diagnosis and management of BOO due to BPH. As the value of these tools is variable, the creation of a logical and objective algorithm was not possible and the treatment is based on the interpretation of clinical symptoms.


Assuntos
Humanos , Masculino , Adulto , Idoso , Idoso de 80 Anos ou mais , Hiperplasia Prostática/diagnóstico , Obstrução do Colo da Bexiga Urinária/diagnóstico , Sintomas do Trato Urinário Inferior/diagnóstico , Tamanho do Órgão , Próstata/patologia , Hiperplasia Prostática/fisiopatologia , Hiperplasia Prostática/patologia , Qualidade de Vida , Padrões de Referência , Micção/fisiologia , Urodinâmica/fisiologia , Obstrução do Colo da Bexiga Urinária/fisiopatologia , Obstrução do Colo da Bexiga Urinária/patologia , Inquéritos e Questionários , Análise de Regressão , Ultrassonografia/métodos , Estatísticas não Paramétricas , Exame Retal Digital , Sintomas do Trato Urinário Inferior/fisiopatologia , Sintomas do Trato Urinário Inferior/patologia , Pessoa de Meia-Idade
2.
Int. braz. j. urol ; 43(1): 95-103, Jan.-Feb. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-840801

RESUMO

ABSTRACT Objectives To investigate the impact of neck circumference (NC) in the treatment of bening prostatic hyperplasia (BPH) patients with metabolic syndrome (MtS). Additionally, we determined dose response to alpha-blockers and cut-off values for NC and waist circumference (WC), in these patients. Materials and Methods Non-randomized, open-labelled, and multi-centre study was conducted between March 2014 and September 2015. The BPH patients were enrolled and were divided into 2 groups: with MtS (Group 1; n=94) and without MtS (Group 2; n=103). Demographic data, anthropometric measurements, blood analyses, uroflowmetric parameters, post voiding residual urine (PVR), prostate volume, quality of life (QoL) index, NC and WC were recorded. Both groups were administered oral alpha-blockers and response to treatment was evaluated. Receiver-operating characteristic (ROC) curves were obtained and significant p was p<0.05 . Results In total, 197 patients were enrolled with mean age of 60.5±8.1 years. Mean NC and WC were higher in MtS patients (p<0.001). Uroflowmetry parameters and QoL indexes were comparable between groups before treatment. International prostate symptom score, uroflowmetry parameters, and QoL significant improved in Group 2 than Group 1, at 1 st and 6 th months of treatment with alpha-blockers. Success rate of treatment was significant higher in Group 2 than Group 1 (p<0.001). Cut-off values were 42.5cm and 113.5cm for NC and WC respectively, for response to alpha-blockers in BPH patients with MtS. Conclusions MtS can be related with BPH and can negatively affect the response to alpha-blocker treatment. NC can be used for predicting response to alpha-blocker treatment in BPH patients with MtS.


Assuntos
Humanos , Masculino , Idoso , Hiperplasia Prostática/fisiopatologia , Hiperplasia Prostática/tratamento farmacológico , Antagonistas Adrenérgicos alfa/uso terapêutico , Síndrome Metabólica/complicações , Síndrome Metabólica/fisiopatologia , Circunferência da Cintura/fisiologia , Pescoço/anatomia & histologia , Qualidade de Vida , Valores de Referência , Índice de Massa Corporal , Valor Preditivo dos Testes , Estudos Prospectivos , Reprodutibilidade dos Testes , Curva ROC , Análise de Variância , Resultado do Tratamento , Antígeno Prostático Específico/sangue , Tamanho Corporal/fisiologia , Relação Dose-Resposta a Droga , Pessoa de Meia-Idade
3.
Int. braz. j. urol ; 42(3): 540-545, tab, graf
Artigo em Inglês | LILACS | ID: lil-785726

RESUMO

ABSTRACT This prospective analysis assessed the effect of histological prostatitis on lower urinary tract functions and sexual function. The patients were separated into two groups as histologically observed prostatitis (Group A) and no prostatitis (Group B) according to the biopsy outcomes. International prostate symptom score, international index of erectile function-5 scores, maximal and average flow rate, and residual urine volumes were compared statistically between groups. There was no significant difference (P>0.05) in baseline age (t=0.64), body mass index value (t=0.51), prostate volume (t=0.87), prostate-specific antigen levels (t=0.43), maximal (t=0.84) and average flow rate (t=0.59), and post-void residual urine volume (t=0.71). Mean international prostate symptom score in patients with prostatitis was numerically but not significantly higher than that in those without prostatitis (t=0.794, P=0.066). Mean international index of erectile function-5 score in the prostatitis group was significantly lower than that in those without prostatitis (t=1.854, P=0.013). Histological prostatitis notably affected sexual function of patients and may serve as a major risk factor for sexual dysfunction while having little effect on lower urinary tract symptoms.


Assuntos
Humanos , Masculino , Idoso , Prostatite/fisiopatologia , Prostatite/patologia , Sintomas do Trato Urinário Inferior/fisiopatologia , Disfunção Erétil/fisiopatologia , Tamanho do Órgão , Próstata/patologia , Hiperplasia Prostática/fisiopatologia , Hiperplasia Prostática/patologia , Biópsia por Agulha , Índice de Gravidade de Doença , Índice de Massa Corporal , Doença Crônica , Análise Multivariada , Estudos Prospectivos , Antígeno Prostático Específico/sangue , Estatísticas não Paramétricas , Progressão da Doença , Sintomas do Trato Urinário Inferior/patologia , Disfunção Erétil/patologia , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA